ENTITY
New Horizon Health

New Horizon Health (6YZ GR)

61
Analysis
Health Care • China
New Horizon Health Limited is a China-based investment holding company focused on early cancer screening and in-home testing, with an emphasis on colorectal, gastric, and cervical cancers. Its key products include ColoClear and Pupu Tube. The company was founded in 2015 and is headquartered in Hangzhou, China.
more
bullish•New Horizon Health
•10 Jan 2021 21:14

New Horizon Health IPO Initiation: Screening for Cancer

New Horizon will have a listing hearing for a $300 million HK IPO this week. We believe that New Horizon has the right ingredients to capitalise on...

Logo
621 Views
Share
bullish•Yidu Tech
•10 Jan 2021 13:45

ECM Weekly (10 January 2021) - RLX Technology, Roiserv, Yidu Tech, and Placements

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
bullish•New Horizon Health
•30 Dec 2020 21:52

New Horizon IPO: Leaning Positive

New Horizon Health is a cancer diagnostics company that plans to list on the HKEX. The company has innovative tests for CRC, gastric, and...

Share
bearish•New Horizon Health
•03 Dec 2020 09:28

Pre-IPO New Horizon Health (NHH.HK) - Here Are the Concerns

This article summarized the concerns for the New Horizon Health in terms of product commercialization, penetration rate of core products, financial...

Logo
592 Views
Share
bullish•New Horizon Health
•26 Nov 2020 13:59

New Horizon Health (诺辉偄康) Pre-IPO: A Hot Medical Device Deal in Making

The company's product has a huge unmet market and a high barrier to entry. We believe its uniqueness as the only investable stock in the segment...

Logo
967 Views
Share
x